" class="no-js "lang="en-US"> Matt Farrar Archives - Medtech Alert
Tuesday, May 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Healthcare is failing Gen Z - New innovation offers potential 97% saving to NHS

LovedBy, the health technology and consultancy business, today announces the launch of ‘Nudg with Dexcom’ […]

LovedBy and Dexcom Announce Partnership to Help Adolescent Diabetes Patients

LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]

LovedBy Hires Former AXA Health Executive Arup Paul as Clinical Director

LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more